Recombinant Human Anti-OR2T1 Soluble TCR (NC7) (C-Cys) (CAT#: VS-0622-YF4786)
Human TCR (NC7) recognizes OR2T1 peptide (FLNVLFPLL) in the context of HLA-A2. Soluble TCR is expressed with C-terminal Cys strategy (TRAV-TRAC partial-Cys, TRBV-TRBC partial-Cys). Depending the C-terminal Cys, two chains form heterodimer. Please note that the activity is not guaranteed.
Specific Inquiry
Specifications
- Host Species
- Human
- Target
- OR2T1
- Epitope
- FLNVLFPLL
- MHC
- HLA-A2
- Clone
- NC7
- Type
- Soluble TCR (C-Cys)
- TCR Expression Strategy
- C-Cys strategy: the alpha and beta chain (without transmembrane and cytosolic region) can form heterodimer based on C-terminal Cys. The soluble TCR contains variable regions and partial constant regions.
Target
- Alternative Names
- Olfactory Receptor Family 2 Subfamily T Member 1 variant FLN_F5L; FLNVLFPLL
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Clone NC7"
Customer Reviews and Q&As
There are currently no Customer reviews or questions for VS-0622-YF4786. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: ELISA, Neut, IF, IP, FC, FuncS
Application: IP, IF, FuncS, FC, Neut, ELISA, ICC
Application: ELISA, IP, FC, FuncS, Neut, IF, ICC
Application: ELISA, IP, FC, FuncS, Neut, IF, ICC
Application: ELISA, IF, Block, FuncS
Application: ELISA, Cyt, PP, Inhib
For Research Use Only. Not For Clinical Use.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
